Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
Titel:
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
Auteur:
Stupp, R. Tosoni, A. Bromberg, J.E.C. Hau, P. Campone, M. Gijtenbeek, J. Frenay, M. Breimer, L. Wiesinger, H. Allgeier, A. van den Bent, M.J. Bogdahn, U. van der Graaf, W. Yun, H.J. Gorlia, T. Lacombe, D. Brandes, A.A.